These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 39281418)
1. The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and meta-analysis. Kanbay M; Brinza C; Ozbek L; Guldan M; Sisman U; Copur S; Covic A; Scripcariu DV; Burlacu A; Covic A Clin Kidney J; 2024 Sep; 17(9):sfae255. PubMed ID: 39281418 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031 [TBL] [Abstract][Full Text] [Related]
5. Lower circulating soluble Klotho level is associated with increased risk of all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis. Charoenngam N; Ponvilawan B; Ungprasert P Int Urol Nephrol; 2020 Aug; 52(8):1543-1550. PubMed ID: 32462356 [TBL] [Abstract][Full Text] [Related]
6. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Edmonston D; Fuchs MAA; Burke EJ; Isakova T; Wolf M; Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756 [TBL] [Abstract][Full Text] [Related]
7. Antioxidants for chronic kidney disease. Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis. Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751 [TBL] [Abstract][Full Text] [Related]
9. Correlation between Soluble Wang Q; Su W; Shen Z; Wang R Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331 [TBL] [Abstract][Full Text] [Related]
10. Dietary glycation compounds - implications for human health. Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724 [TBL] [Abstract][Full Text] [Related]
11. Oral adsorbents for preventing or delaying the progression of chronic kidney disease. Wu HM; Sun HJ; Wang F; Yang M; Dong BR; Liu GJ Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007861. PubMed ID: 25317905 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774 [TBL] [Abstract][Full Text] [Related]
14. Adverse Pregnancy Outcomes and Long-term Maternal Kidney Disease: A Systematic Review and Meta-analysis. Barrett PM; McCarthy FP; Kublickiene K; Cormican S; Judge C; Evans M; Kublickas M; Perry IJ; Stenvinkel P; Khashan AS JAMA Netw Open; 2020 Feb; 3(2):e1920964. PubMed ID: 32049292 [TBL] [Abstract][Full Text] [Related]
15. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712 [TBL] [Abstract][Full Text] [Related]
16. Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease. Yang K; Yang J; Bi X; Yu Z; Xiao T; Huang Y; Liu Y; Xiong J; Zhao J Cardiorenal Med; 2020; 10(3):175-187. PubMed ID: 32294646 [TBL] [Abstract][Full Text] [Related]
17. Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies. Yu LX; Sha MY; Chen Y; Tan F; Liu X; Li S; Liu QF Ther Adv Chronic Dis; 2023; 14():20406223231213246. PubMed ID: 38058396 [TBL] [Abstract][Full Text] [Related]
18. Interventions for weight loss in people with chronic kidney disease who are overweight or obese. Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940 [TBL] [Abstract][Full Text] [Related]
19. Low Klotho/Fibroblast Growth Factor 23 Ratio Is an Independent Risk Factor for Renal Progression in Chronic Kidney Disease: Finding From KNOW-CKD. Kim HJ; Kim Y; Kang M; Kim S; Park SK; Sung S; Hyun YY; Jung JY; Ahn C; Oh KH Front Med (Lausanne); 2022; 9():904963. PubMed ID: 35872753 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of left ventricular global longitudinal strain in chronic kidney disease patients: a systematic review and meta-analysis. Zhang T; Li J; Cao S Int Urol Nephrol; 2020 Sep; 52(9):1747-1756. PubMed ID: 32495023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]